Clinical Trial Update: Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, pharmacokinetics, and anti-viral activity of VRC01 and VRC01LS in healthy HIV-uninfected adults with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• VRC01 (VRC01)
• VRC01LS (VRC01LS)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2021-01-08